Utkarsh Micro Finance(Core Invest)Unlisted Shares
₹ 125▼28.57%(50.00)
About the company
Modify and rewrite the About section to make it more human-friendly, natural, engaging, and professional. Make the content slightly longer by adding relevant and useful information while maintaining a smooth and conversational flow.
Keep the content SEO-friendly, but use keywords naturally without keyword stuffing. Avoid overly complex or AI-sounding language.
Important Note: Do not mention or include the names of any competitors anywhere in the content, such as UnlistedZone or any other competing brand or platform.
Fundamentals
Valuation
- 52 week high
- ₹205
- 52 week low
- ₹125
- P/B ratio
- 0.49
- ROE (%)
- -16.82%
- Book value
- ₹253.42
- Face value
- ₹10
- Valuation
- —
Registry
- ISIN number
- INE396P01012
Figures in cr ·
Financials
| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| PAT | 62 | 554 | 330 | -422 |
| EPS | 6.31 | 56.3 | 33.43 | -42.5 |
| Interest earned | 1,961 | 2,723 | 3093 | 3485 |
| Interest expended | 799 | 1025 | 1298 | 1714 |
| Other income | 134 | 215 | 291 | 304 |
| Operating expenses | 760 | 956 | 1,205 | 1627 |
| Provisions & contingencies | 454 | 226 | 378 | 1370 |
| Gross NPA (%) | 6.1 | 3.23 | 2.51 | 9.4 |
| Net NPA (%) | 2.31 | 0.39 | 0.03 | 4.84 |
Shareholding Pattern
Leadership
Frequently asked questions
Common questions on Utkarsh Micro Finance(Core Invest) Unlisted Shares—tap a row to read the answer.
Q.1What is Utkarsh CoreInvest Limited?
Utkarsh CoreInvest Limited, formerly known as Utkarsh Micro Finance Limited, is the promoter and holding company of Utkarsh Small Finance Bank. It primarily holds its investment in the bank and plays a strategic role in supporting its long-term growth and governance.
Q.2What should investors evaluate before investing in Utkarsh CoreInvest Limited?
Before investing, consider factors such as the company's role as a holding company, the performance of its underlying investments, financial statements, management quality, valuation, corporate governance, future growth prospects, and the overall outlook for India's banking and financial services sector.
Q.3What are the risks of investing in Utkarsh CoreInvest Limited unlisted shares?
Like all unlisted investments, these shares may involve risks such as limited liquidity, price volatility, lower public disclosures, and uncertainty regarding future listing opportunities. Investors should carefully evaluate these risks and invest according to their financial objectives and risk appetite.
Q.4Does Utkarsh CoreInvest Limited have plans for an IPO?
As of now, there is no officially announced IPO timeline for Utkarsh CoreInvest Limited. If the company decides to pursue a public listing in the future, any updates are expected to be communicated through official company announcements and regulatory filings
Q.5How is the price of Utkarsh CoreInvest Limited unlisted shares determined?
The price of Utkarsh CoreInvest Limited unlisted shares is influenced by several factors, including the value of its investments, financial performance, investor demand, market sentiment, industry outlook, and recent transactions in the unlisted shares market.
Q.6Is there a lock-in period for Utkarsh CoreInvest Limited unlisted shares?
Generally, there is no lock-in period for shares acquired through valid off-market transactions. However, if the company is listed in the future, lock-in provisions may apply to certain categories of shareholders in accordance with applicable regulations.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
